Meeting News
May 7, 2018
LAS VEGAS — Patients with type 2 diabetes who received a continuous care treatment including nutritional ketosis improved biomarkers of CVD…
Meeting NewsVideo
May 6, 2018
In this Cardiology Today video exclusive, Seth S. Martin, MD, MHS, FACC, FAHA, assistant professor of medicine and co-director of the Advanced Lipid…
Meeting News
May 4, 2018
LAS VEGAS — Patients with familial chylomicronemia syndrome who were connected actively or passively through a support group had improved…
Meeting News
May 3, 2018
LAS VEGAS — A novel method using non-HDL and triglyceride values estimated LDL better than the Friedewald method in patients who reduced their…
Meeting News
May 1, 2018
LAS VEGAS — Inclisiran, an RNA interference therapeutic targeting PCSK9, safely reduced LDL in various patient populations and subgroups…
Meeting News
April 30, 2018
LAS VEGAS — Lipid apheresis can significantly reduce lipoprotein(a) levels compared with available drug therapies, according to a presentation…
Meeting News
April 29, 2018
LAS VEGAS — Plant-based diets can reduce risk for CV-related events and mortality as effectively as pharmacotherapies, according to a…
Meeting News
April 28, 2018
LAS VEGAS — Nonstatin therapies such as ezetimibe and PCSK9 inhibitors reduce the risk for CVD in patients who require additional LDL…
Meeting News
April 28, 2018
LAS VEGAS — Hormone therapy in transgender men and women increased CV risk, according to a presentation at the National Lipid Association…
Meeting News
April 27, 2018
LAS VEGAS — Early initiation of statin therapy may reduce CV risk in children with familial hypercholesterolemia, according to a presentation…